Rapidly Expanding Field of Gene Therapy $NTLA

Pembelian

Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Diupdate

NASDAQ:NTLA Intellia Therapeutics, Inc.

indicator chartpattern genetherapy biopharma

I have know about this stock for over a year now, but I have never put the time into charting it. The time is near to buy in, and the patient investor will wait for the MACD to bottom out then buy.

Komentar:

There has been some slight turbulence in the markets as of late, but to maintain trend lines is key. I did buy in @$21.40 and as long as the price continues to stay above my trend lines I will not sell a share.

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.